Vascular endothelial cells on two- And three-dimensional fibrin assemblies for biomaterial coatings

Journal of Biomedical Materials Research - Part A

Volumn 90, Issue 1, 2009, Pages 55-69

  Filová, Elena ^a,b   Brynda, Eduard ^c   Riedel, Tomáš ^c,d   Bačáková, Lucie ^a,b   Chlupáč, Jaroslav ^a,b   Lisá, Věra ^a   Houska, Milan ^c   Dyr, Jan E ^d  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b Centre for Experimental Cardiovascular Research   (Czech Republic)

^c INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Czech Republic)

^d INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

Artificial fibrin networks; Endothelial cells; Nanostructure; Surface modification; Von Willebrand factor

Indexed keywords

ANTITHROMBIN III; ARTIFICIAL FIBRIN NETWORKS; BIOMATERIAL COATINGS; CELL SPREADING; CONCENTRATION OF; FIBRIN NETWORK; FIBROUS SCAFFOLDS; IN-SITU; POLY LACTIDE; POPULATION DENSITIES; PULMONARY ARTERY ENDOTHELIAL CELLS; SURFACE MODIFICATION; SYNTHETIC SURFACES; THROMBIN INHIBITORS; ULTRA-THIN; VASCULAR ENDOTHELIAL CELLS; VINCULIN; VON WILLEBRAND FACTOR;

ADSORPTION; BIOLOGICAL MATERIALS; BLOOD VESSEL PROSTHESES; CELL MEMBRANES; ELECTRIC CONDUCTIVITY MEASUREMENT; FLOATING BREAKWATERS; GELATION; MORPHOLOGY; NANOSTRUCTURES; POLYSACCHARIDES; POLYSTYRENES; SCANNING ELECTRON MICROSCOPY; SELF ASSEMBLY; SURFACE PLASMON RESONANCE; SURFACE TREATMENT; THREE DIMENSIONAL; TWO DIMENSIONAL;

ENDOTHELIAL CELLS;

ANTITHROMBIN III; BETA ACTIN; BIOMATERIAL; CD51 ANTIGEN; FIBRINOGEN; HEPARIN; POLYLACTIDE; POLYSTYRENE; THROMBIN; VINCULIN; VON WILLEBRAND FACTOR;

ADSORPTION; ANIMAL CELL; ARTICLE; CATALYSIS; CELL ADHESION; CELL COUNT; CELL DENSITY; CELL DIFFERENTIATION; CELL GROWTH; CELL LEVEL; CELL SPREADING; CELL STRUCTURE; ENDOTHELIUM CELL; FIBRIN POLYMERIZATION; HUMAN; IMMUNOFLUORESCENCE; MATERIAL COATING; NONHUMAN; VASCULAR ENDOTHELIUM;

ACTINS; ADSORPTION; ANIMALS; ANTITHROMBIN III; CATTLE; CELL CULTURE TECHNIQUES; CELLS, CULTURED; COATED MATERIALS, BIOCOMPATIBLE; ENDOTHELIAL CELLS; FIBRIN; FIBRINOGEN; GELS; HEPARIN; HUMANS; INTEGRIN ALPHAV; MATERIALS TESTING; POLYESTERS; SURFACE PROPERTIES; THROMBIN; TISSUE SCAFFOLDS; VINCULIN; VON WILLEBRAND FACTOR;

EID: 66849104320     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32065     Document Type: Article

References (28)

1. Colman RW, Marder VJ, Clowes AW. Overview of coagulation, fibrinolysis, and their regulation. In: Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, editors. Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.
2. Weisel JW. The electron microscope band pattern of human fibrin: Various stains, lateral order, and carbohydrate localization. J Ultrastruct Mol Struct Res 1986;96:176-188. (Pubitemid 18006231)
3. Di Cera E. Thrombin interactions. Chest 2003;124:11-17. (Pubitemid 37128431)
4. Rubens FD, Weitz JI, Brash JL, Kinlough-Rathbone RI. The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene. Thromb Haemost 1993;69:130-134. (Pubitemid 23041182)
5. Laurens N, Koolwijk P, De Maat PM. Fibrin structure and wound healing. J Thromb Haemost 2006;4:932-939.
6. Makogonenko E, Tsurupa G, Ingham K, Medved L. Interaction of fibrin (ogen) with fibronectin: Further characterization and localization of the fibronectin-binding site. Biochemistry 2002;41:7907-7913. (Pubitemid 34655155)
7. Sahni A, Francis CW. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 2000;96:3772-3778.
8. Tsurupa G, Medved L. Fibrinogen C domains contain cryptic plasminogen and tPA binding sites. Ann NY Acad Sci 2001;936:328-330. (Pubitemid 32613917)
9. Clark RAF. Fibrin and wound healing. Ann NYAcad Sci 2001;936:355-367.
10. Jackson MR. Fibrin sealant in surgical practice: An overview. Am J Surg 2001;182:1-7. (Pubitemid 32898601)
11. Bense CA, Woodhouse KA. Plasmin degradation of fibrin coatings on synthetic polymer substrates. J Biomed Mater Res 1999;46:305-314. (Pubitemid 29293752)
12. Stegemann JP, Nerem RM. Phenotype modulation in vascular tissue engineering using biochemical and mechanical stimulation. Ann Biomed Eng 2003;31:391-402.
13. Jockenhoevel S, Zund G, Hoerstrup SP, Chalabi K, Sachweh JS, Demircan L, Messmer BJ, Turina M. Fibrin gel-advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardiothorac Surg 2001;19:424-430. (Pubitemid 32297774)
14. Mola A, van Lieshouta MI, Dam-de Veena CG, Neuenschwanderb S, Hoerstrupb SP, Baaijensa FPT, Bouten CVC. Fibrin as a cell carrier in cardiovascular tissue engineering applications. Biomaterials 2005;26:3113-3121.
15. Hokugo A, Takamoto T, Tabata Y. Preparation of hybrid scaffold from fibrin and biodegradable polymer fiber. Biomaterials 2006;27:61-67. (Pubitemid 41225369)
16. Riedel T, Brynda E, Lesný P, Jendelová P, Syková E, Dyr JE, Houska M.Three-dimensional fibrin scaffolds, 43rd Microsymposium 'Polymer Biomaterials: Biomimetic and Bioanalogous Systems', Prague 2004, PC46.
17. Cardon A, Chakfé N, Thaveau F, Gagnon E, Hartung O, Aillet S, Kerdiles Y, Dion YM, Kretz JG, Doillon CHJ. Sealing of polyester prostheses with autologous fibrin glue and bone marrow. Ann Vasc Surg 2000;14:543-552.
18. Walpoth BH, Bowlin GL. The daunting quest for a small diameter vascular graft. Expert Rev Med Devices 2005;2:647-651. (Pubitemid 41699893)
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
20. Brynda E, Houska M, Lednický F. Adsorption of human fibrinogen onto hydrophobic surface: The effect of concentration in solution. J Colloid Interface Sci 1986;113:164-171. (Pubitemid 16610299)
21. Dyr JE, Tichý I, Jiroušková M, Tobiška P, Slavík R, Homola J, Brynda E, Houska M, Suttnar J. Molecular arrangement of adsorbed fibrinogen molecules characterized by specific monoclonal antibodies and a surface plasmon resonance sensor. Sens Actuators B 1998;51:268-272. (Pubitemid 128433392)
22. Wolberg AS. Thrombin generation and fibrin clot structure. Blood Rev 2007;21:132-142. (Pubitemid 46541695)
23. Fuchs S, Motta A, Migliaresi C, Kirkpatrick CJ. Outgrowth endothelial cells isolated and expanded from human peripheral blood progenitor cells as a potential source of autologous cells for endothelialization of silk fibroin biomaterials. Biomaterials 2006;27:5399-5408. (Pubitemid 44093717)
24. Sottile J. Regulation of angiogenesis by extracellular matrix. Biochim Biophys Acta 2004;1654:13-22. (Pubitemid 38230928)
25. 3. Blood 1995;86:2606-2615.
26. Chlupáč J, Filová E, Riedel T, Brynda E, Remy-Zolghadri M, Bareille R, Fernandez P, Daculsi R, Bordenave L, Bačáková L. Human endothelium on vascular prostheses modified by extracellular matrix proteins in a flow experiment. Eng Biomater 2006;9:10-13.
27. Xue L, Greisler HP. Angiogenic effect of fibroblast growth factor-1 and vascular endothelial growth factor and their synergism in a novel in vitro quantitative fibrin-based 3-dimensional angiogenesis system. Surgery 2002;132:259-267. (Pubitemid 35024771)
28. Ye Q, Zund G, Benedikt P, Jockenhoevel S. Hoerstrup SP, Sakyama S, Hubbell JA, Turina M. Fibrin gel as a three dimensional matrix in vascular tissue engineering. Eur J Cardiothorac Surg 2000;17:587-591. (Pubitemid 30256271)